Paulina Selaru

3.9k citations
27 papers · 2.4k indexed · 1 hit paper · h-index 16
Topics
Lung Cancer Treatments and Mutations (22 papers)Lung Cancer Research Studies (11 papers)Colorectal Cancer Treatments and Studies (9 papers)
Partner nations
United StatesItalyChina

In The Last Decade

Paulina Selaru

26 papers receiving 2.3k citations

Hit Papers

Clinical Experience With Crizotinib in Patients With Adva...20152026201820222015100200300400

Peers

Paulina Selaru
Comparison fields: 5 of 69
  • Pulmonary and Respiratory Medicine 1.8k
  • Oncology 1.4k
  • Molecular Biology 819
  • Cancer Research 285
  • Pathology and Forensic Medicine 231
Replace David McCollum with:
David McCollum United States
Enrico Ricevuto Italy
Shinichi Tsutsui Japan
D. J. Richel Netherlands
Alessio Amatu Italy
J. Pablo Arnoletti United States
Hirohisa Kitagawa Japan
Florian Heitz Germany
Khaldoun Almhanna United States
Takeru Wakatsuki Japan
Paulina Selaru relative to David McCollum United States David McCollum's profile →
Citations per field
00.5×3.6×
David McCollum · 1×
Citations per year

Countries citing papers authored by Paulina Selaru

Since Specialization
Citations

This map shows the geographic impact of Paulina Selaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paulina Selaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paulina Selaru more than expected).

Fields of papers citing papers by Paulina Selaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paulina Selaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paulina Selaru. The network helps show where Paulina Selaru may publish in the future.

Co-authorship network of co-authors of Paulina Selaru

This figure shows the co-authorship network connecting the top 25 collaborators of Paulina Selaru. A scholar is included among the top collaborators of Paulina Selaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paulina Selaru. Paulina Selaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 137
2 74
3 0
4
Intracranial efficacy of first-line crizotinib vs. chemotherapy in ALK-positive NSCLC
1
5
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasesbreakdown →
468
6 170
7 47
8 36
9 14
10 28
11 53
12 188
13 4
14 110
15 1
16
Effect of food on the pharmacokinetics of Axitinib (AG-013736) in healthy volunteers
3
17 28
18
Clinical aspects of a phase I study of PD-0325901, a selective oral MEK inhibitor, in patients with advanced cancer
13
19 49
20 266

About Paulina Selaru

Paulina Selaru is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Ophthalmology, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (11 papers) and Colorectal Cancer Treatments and Studies (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.8k citations), Oncology (1.4k citations) and Cancer Research (285 citations). Paulina Selaru has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Keith D. Wilner, Gregory J. Riely, Lucio Crinò, Benjamin Solomon, Daniel B. Costa, Richard C. Chao, L. Tye, Ramaswamy Govindan, Giorgio V. Scagliotti and Alice T. Shaw. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026